Skip to content
Buy This GLP
← Research
Evidence

Can a GLP-1 Cause Low Blood Sugar? How Insulin Changes the Risk

Taking a GLP-1 with insulin can raise the risk of low blood sugar. Trials of post-bariatric hypoglycemia address a different cause.

Editorial profile: Carla MedinaBuy This GLP Editorial Team9 min read
The same receptor, drugged in opposite directionsSemaglutide, tirzepatideswitch the receptor ONless appetite, less weightAvexitideswitches it OFFfewer hypoglycemic eventsReductions against each participant’s own two-week run-insevere events−67.5%time below 54 mg/dL−64%daytime level 2 events−59%16 participants. No placebo arm — the comparison is with themselves, before.

Semaglutide stimulates insulin release in response to glucose. Its prescribing information warns that people taking insulin or a sulfonylurea alongside it may be more likely to develop hypoglycemia [4]. Our guide to how a GLP-1 fits with your existing medicines helps you prepare questions for your visit. If you take either medicine, discuss the combination with the clinician who manages your diabetes.

What the insulin trials measured

The semaglutide trial with automated insulin delivery studied adults with type 1 diabetes in a separate setting. The results below describe different medicines and study populations.

In REIMAGINE 3, adding cagrilintide-semaglutide to basal insulin lowered HbA1c more than placebo in adults with type 2 diabetes. The study reported no severe hypoglycemia [3]. Its group averages cannot determine whether an individual needs a change in insulin dose.

A separate 26-week trial randomized 72 adults with type 1 diabetes and obesity who used automated insulin delivery. The study recorded two severe lows in each group and no reported diabetic ketoacidosis [2]. The trial was too small to establish how frequently rare harms occur.

Low blood sugar after bariatric surgery

Post-bariatric hypoglycemia can occur after meals, in part because the gut releases more GLP-1 and stimulates insulin release. The research on GLP-1 treatment around bariatric surgery addresses weight management, a separate question from treating recurrent lows [1].

What the avexitide studies found

In a phase 2b study with 16 completers, daytime level 2 events measured by continuous glucose monitoring fell by 47.7% and 59.0% during two avexitide regimens. The researchers compared each treatment period with the same participants’ run-in period [1].

Frequently asked

What raises the risk of hypoglycemia with semaglutide?
The prescribing information warns that using semaglutide alongside insulin or a sulfonylurea can raise the risk. Ask your prescriber whether your medicines need a review.
Did the semaglutide trial in adults with type 1 diabetes find more severe lows?
The 26-week trial recorded two severe events in each group. With 72 people randomized, it could not rule out differences in uncommon events.
Does avexitide treat post-bariatric hypoglycemia?
Avexitide is investigational. In phase 3, the sponsor reported fewer combined level 2 and level 3 events than with placebo in participants who had gastric bypass.

Sources

  1. [1] Craig C, et al. (2026). Efficacy and safety of avexitide for treatment of hypoglycemia following bariatric and other upper gastrointestinal surgeries: a phase 2b study Metabolism: Clinical and Experimental. PMID 42744082
  2. [2] Shah VN, et al. (2025). Semaglutide in Adults with Type 1 Diabetes and Obesity NEJM Evidence. PMID 40550013
  3. [3] Rosenstock J, Billings LK, Gajria R, Giorgino F, Johansen NB, Klein KR (2026). Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study The Lancet. PMID 42251856
  4. [4] Novo Nordisk (2026). Ozempic prescribing information DailyMed. Source
  5. [5] Amylyx Pharmaceuticals (2026). LUCIDITY phase 3 topline results SEC Form 8-K, Exhibit 99.1. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence